Search results for "double-blind"

showing 10 items of 662 documents

Repetitive Transcranial Magnetic Stimulation (rTMS) Improves Facial Affect Recognition in Schizophrenia

2014

Abstract Objective Facial affect recognition, a basic building block of social cognition, is often impaired in schizophrenia. Poor facial affect recognition is closely related to poor functional outcome; however, neither social cognitive impairments nor functional outcome are sufficiently improved by antipsychotic drug treatment alone. Adjunctive repetitive transcranial magnetic stimulation (rTMS) has been shown to enhance cognitive functioning in both healthy individuals and in people with neuropsychiatric disorders and to ameliorate clinical symptoms in psychiatric disorders, but its effects on social cognitive impairments in schizophrenia have not yet been studied. Therefore, we evaluate…

AdultMalemedicine.medical_specialtymedicine.medical_treatmentBiophysicsPrefrontal CortexStimulationAudiologylcsh:RC321-571Young AdultCognitionDouble-Blind MethodSocial cognitionRepetitive transcranial magnetic stimulation (rTMS)medicineHumansIn patientCognitive skillPsychiatrylcsh:Neurosciences. Biological psychiatry. NeuropsychiatryFacial affectGeneral NeuroscienceMiddle Agedmedicine.diseaseTranscranial Magnetic StimulationFacial affect recognitionTranscranial magnetic stimulationFacial ExpressionAffectSchizophreniaSchizophreniaChronic schizophreniaFemaleSchizophrenic PsychologyNeurology (clinical)PsychologyCognition DisordersBrain Stimulation
researchProduct

Prophylaxis of radiogenic sialadenitis and mucositis by coumarin/troxerutine in patients with head and neck cancer--a prospective,randomized, placebo…

2001

To study the efficacy of coumarin/troxerutine for the protection of salivary glands and mucosa during irradiation. Design: Prospective, randomized, placebo-controlled, double-blind trial. Setting: University hospital, Germany. Patients: 48 patients who had radiotherapy to the head and neck. Main outcome measures: Salivary gland scintigraphy and acute side-effects of radiotherapy (Radiation Therapy Oncology Group (RTOG) score). Results: 23 patients (11 experimental, 12 placebo) completed the study. The global efficacy measure combining scintigraphy and RTOG score favoured the experimental arm (P= 0.07). The RTOG score showed significantly fewer acute side-effects of radiation in the experime…

AdultMalemedicine.medical_specialtymedicine.medical_treatmentRadiation-Protective AgentsPlaceboGastroenterologyXerostomiaSalivary GlandsSialadenitislaw.inventionRandomized controlled trialDouble-Blind MethodlawCoumarinsInternal medicinemedicineMucositisHumansProspective StudiesProspective cohort studyRadiation InjuriesRadionuclide ImagingAgedSodium Pertechnetate Tc 99mbusiness.industryHead and neck cancerMouth MucosaMiddle Agedmedicine.diseaseSialadenitisSurgeryRadiation therapyDrug CombinationsHydroxyethylrutosideTreatment OutcomeOtorhinolaryngologyEpidermoid carcinomaHead and Neck NeoplasmsSurgeryFemaleOral SurgeryCranial IrradiationRadiopharmaceuticalsbusinessThe British journal of oralmaxillofacial surgery
researchProduct

Efficacy and tolerability of multiple-dose SDZ IMM 125 in patients with severe psoriasis.

2006

Although cyclosporin is effective in immunosuppression following organ transplantation and in the treatment of psoriasis, its use is limited by its side-effects, notably impaired renal function and hypertension. As SDZ IMM 125, a new derivative of the cyclosporin family, showed considerable immunosuppressive activity in experimental studies, with less effect on renal function, it was considered a potential successor to cyclosporin for both indications. In this multicentre, double-blind, placebo-controlled study, the efficacy and tolerability of 40, 100, 200 and 400 mg SDZ IMM 125 daily were studied in 59 patients with psoriasis. Patients were followed for a period of 5 weeks (4 weeks treatm…

AdultMalemedicine.medical_specialtymedicine.medical_treatmentRenal functionCyclosporinsDermatologyPharmacologyGastroenterologyDrug Administration ScheduleDouble-Blind MethodInternal medicinePsoriasismedicineHumansPsoriasisAdverse effectBody surface areaChemotherapyDose-Response Relationship Drugbusiness.industryImmunosuppressionMiddle Agedmedicine.diseaseTolerabilityToxicityFemalebusinessImmunosuppressive AgentsFollow-Up StudiesThe British journal of dermatology
researchProduct

Effect of irrigation of the nose with isotonic salt solution on adult patients with chronic paranasal sinus disease

2001

In a prospective, randomized, controlled, double-blind trial we compared the effectiveness of endonasal irrigations with Ems salt solution to that with sodium chloride solution in the treatment of adult patients with chronic paranasal sinus disease. Subjects (n = 40) were randomly allocated to treatment either with isotonic Ems salt solution or with isotonic sodium chloride solution. The treatment consisted of endonasal irrigation twice daily and additional nasal spray as required. Nasal endoscopy, plain radiography of the paranasal sinuses, olfactometry, anterior rhinomanometry, and a saccharin-clearance test were carried out on days 1 and 7. Patients recorded rating scales of general disc…

AdultMalemedicine.medical_specialtymedicine.medical_treatmentTherapeutic irrigationSodium ChlorideDouble-Blind Methodmedicineotorhinolaryngologic diseasesHumansSinusitisTherapeutic IrrigationSinusitisNosemedicine.diagnostic_testbusiness.industryChronic sinusitisGeneral Medicinemedicine.diseaseSurgeryEndoscopyTreatment OutcomeParanasal sinusesmedicine.anatomical_structureOtorhinolaryngologyNasal sprayAnesthesiaChronic DiseaseFemaleNasal ObstructionRhinomanometrybusiness
researchProduct

TRANSCRANIAL DIRECT CURRENT STIMULATION ENHANCES SUCKING OF A LIQUID BOLUS IN HEALTHY HUMANS

2014

Abstract Background Transcranial direct current stimulation (tDCS) is a non-invasive technique used for modulating cortical excitability in vivo in humans. Here we evaluated the effect of tDCS on behavioral and electrophysiological aspects of physiological sucking and swallowing. Methods Twelve healthy subjects underwent three tDCS sessions (anodal, cathodal and sham stimulation) on separate days in a double-blind randomized order. The active electrode was placed over the right swallowing motor cortex. Repeated sucking and swallowing acts were performed at baseline and at 15 and 60 min after each tDCS session and the mean liquid bolus volume ingested at each time point was measured. We also…

AdultMalemedicine.medical_treatmentBiophysicsElectromyographySuctionTranscranial Direct Current StimulationtDCSlcsh:RC321-571Young AdultDouble-Blind MethodSwallowingstomatognathic systemmedicineHumansMuscle Skeletallcsh:Neurosciences. Biological psychiatry. NeuropsychiatryBrain stimulation; Dysphagia; Electromyography; Suction; Swallowing; tDCSAgedmedicine.diagnostic_testTranscranial direct-current stimulationElectromyographyGeneral NeuroscienceMotor CortexDysphagiaMiddle AgedSwallowingDysphagiaHealthy VolunteersDeglutitionElectrophysiologymedicine.anatomical_structureBrain stimulationSucking BehaviorAnesthesiaBrain stimulationPharynxFemaleSettore MED/26 - NeurologiaNeurology (clinical)Larynxmedicine.symptomBolus (digestion)Deglutition DisordersPsychologyMotor cortex
researchProduct

Effects of post-extinction l-DOPA administration on the spontaneous recovery and reinstatement of fear in a human fMRI study

2015

Relapse is a pertinent problem in the treatment of anxiety disorders. In the laboratory, relapse is modeled as return of conditioned fear responses after successful fear extinction and is explained by insufficient retrieval and/or expression of the fear-inhibitory extinction memory that is generated during extinction learning. We have shown in mice and humans that return of fear can be prevented by administration of a single dose of the dopamine precursor l-3,4-dihydroxyphenylalanine (l-DOPA) immediately after extinction. In mice, this effect could be attributed to an enhancement of extinction memory consolidation. In our human study, we could not exclude that l-DOPA might have acted by int…

AdultMalemedicine.medical_treatmentDopamine AgentsSpontaneous recoveryExposure therapyVentromedial prefrontal cortexAmygdalaFear-potentiated startleExtinction PsychologicalDevelopmental psychologyLevodopaRandom AllocationDouble-Blind MethodConditioning PsychologicalmedicineHumansPharmacology (medical)Fear conditioningBiological PsychiatryMemory ConsolidationPharmacologyFear processing in the brainBrain MappingPsychotropic DrugsBrainFearGalvanic Skin Responsesocial sciencesExtinction (psychology)Magnetic Resonance ImaginghumanitiesPsychiatry and Mental healthmedicine.anatomical_structureNeurologyVisual PerceptionNeurology (clinical)CuesPsychologyNeuroscienceEuropean Neuropsychopharmacology
researchProduct

Long term structural effects of combination therapy in patients with early rheumatoid arthritis: five year follow up of a prospective double blind co…

2003

Objective: To evaluate whether early combined therapy with methotrexate (MTX) and sulfasalazine (SSZ) during the first year in early rheumatoid arthritis (RA) induces long term beneficial effects, compared with monotherapy, when the further treatment strategy is a free choice. Methods: Study design: five year multicentre prospective longitudinal trial. Participants: 146/205 patients with RA previously included in a one year prospective randomised trial comparing the effects of treatment with MTX, SSZ, or a combination of both. Criteria for inclusion: patients with early RA (⩽1 year duration). Follow up: between the end of years 1 and 5, patients were followed up and treated by their own rhe…

AdultMalemusculoskeletal diseasesmedicine.medical_specialtyConcise ReportCombination therapymedicine.medical_treatmentImmunologyArthritisSeverity of Illness IndexGeneral Biochemistry Genetics and Molecular Biologylaw.inventionArthritis RheumatoidDouble-Blind MethodRheumatologyRandomized controlled triallawSulfasalazineInternal medicinemedicineHumansImmunology and AllergyProspective StudiesDisease-modifying antirheumatic drugskin and connective tissue diseasesProspective cohort studyAgedAnalysis of Variancebusiness.industryMiddle Agedmedicine.diseaseSurgerySulfasalazineClinical trialMethotrexateTreatment OutcomeAntirheumatic AgentsRheumatoid arthritisDrug Therapy CombinationFemalebusinessFollow-Up Studiesmedicine.drugAnnals of the Rheumatic Diseases
researchProduct

Wheat consumption leads to immune activation and symptom worsening in patients with familial mediterranean fever : a pilot randomized trial

2020

We have identified a clinical association between self-reported non-celiac wheat sensitivity (NCWS) and Familial Mediterranean Fever (FMF). Objectives: A) To determine whether a 2-week double-blind placebo-controlled (DBPC) cross-over wheat vs. rice challenge exacerbates the clinical manifestations of FMF

AdultMalenon-celiac wheat sensitivityCD14 lymphocytesLipopolysaccharide Receptors610 Medizinlcsh:TX341-641Wheat HypersensitivityMonocytesArticleDouble-Blind MethodAIDAI score610 Medical sciencesHumansTriticumCross-Over Studiesinterleukin-1betaTumor Necrosis Factor-alphaCD14 lymphocytefood and beveragesFamilial Mediterranean FeverDisease ProgressionFemaletumor necrosis factor-αlcsh:Nutrition. Foods and food supplyamylase trypsin inhibitor
researchProduct

Efficacy and pharmacological appropriateness of cinnarizine and dimenhydrinate in the treatment of vertigo and related symptoms

2021

Vertigo is not itself a disease, but rather a symptom of various syndromes and disorders that jeopardize balance function, which is essential for daily activities. It is an abnormal sensation of motion that usually occurs in the absence of motion, or when a motion is sensed inaccurately. Due to the complexity of the etiopathogenesis of vertigo, many pharmacological treatments have been tested for efficacy on vertigo. Among these drugs, cinnarizine, usually given together with dimenhydrinate, appears to be the first-line pharmacotherapy for the management of vertigo and inner ear disorders. Based on these considerations, the present non-interventional study aimed to investigate the clinical …

AdultMalepharmacological treatment of vertigomedicine.medical_specialtyCinnarizineHealth Toxicology and MutagenesisDiseasedimenhydrinateArticleCinnarizine Dimenhydrinate Dizziness Pharmacological treatment of vertigo Vertigo Adult Double-Blind Method Drug Combinations Female Histamine H1 Antagonists Humans Male Middle Aged Cinnarizine Dimenhydrinatevertigo03 medical and health sciences0302 clinical medicinePharmacotherapyDouble-Blind MethodVertigoInternal medicinemedicineotorhinolaryngologic diseasesHumans030212 general & internal medicinecinnarizine030223 otorhinolaryngologydizzinessBalance (ability)biologybusiness.industryPublic Health Environmental and Occupational HealthRMiddle Agedbiology.organism_classificationDimenhydrinateDrug CombinationsTolerabilityConcomitantHistamine H1 AntagonistsMedicineFemalebusinessmedicine.drug
researchProduct

Double-blind, randomized, placebo-controlled trial of allergen-specific immunotherapy with the major allergen Alt a1

2019

Background: There have been few studies conducted on the efficacy and safety of specific immunotherapy with allergen extracts of fungi compared with other allergen extracts, and there are no data on the major allergen Alt a 1 of the fungus Alternaria alternata. Objectives: We sought to evaluate the efficacy and safety of subcutaneous immunotherapy with 2 different doses of Alt a 1 in patients with rhinoconjunctivitis caused by sensitization to A alternata. Method: We performed a multicenter, randomized, double-blind, placebo-controlled trial with Alt a 1 administered subcutaneously in patients with allergic rhinoconjunctivitis with or without controlled asthma aged 12 to 65 years. Three gro…

AdultMalesafetyAllergymedicine.medical_specialtyAllergen immunotherapyAl·lèrgiaAdolescentImmunologyefficacyPlacebo-controlled studyPlacebomedicine.disease_causeFungal ProteinsYoung AdultAllergenDouble-Blind Methodchildrensubcutaneous immunotherapyInternal medicinemedicineadultsImmunology and AllergyHumansmolecular immunotherapyAdverse effectChildAgedConjunctivitis AllergicAllergen immunotherapyIntention-to-treat analysisbusiness.industryrhinoconjunctivitisclinical trialAllergensImmunoglobulin EMiddle Agedmedicine.diseaseAsthmaClinical trialfungal allergyDesensitization ImmunologicImmunoglobulin GAlt a 1Femalebusinesspurified allergen
researchProduct